Neutralizing antibody production against Rebif® and ReciGen® in Relapsing-Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability
Article in International Immunopharmacology (July 2018)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in International Immunopharmacology (July 2018)
Book (August 2017)
Book chapter (August 2017)